MSLE
Satellos Bioscience Inc.
$9.79
+0.35 (+3.71%)
At close · Jul 10
Market Cap
$206.65M
Shares
20,831,190
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.79
Open$9.34
Day$9.34–10.00
52W$4.64–13.40
Avg vol 30d65K
Short int83K · 0.4% float · 1.7d
Short vol89%
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+31%
above
Price vs 50-day avg
+39%
above
RSI (14)
76
overbought
MACD trend
Positive
52-week position
59%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+67%
trailing
6-month return
+27%
trailing
YTD return
+67%
this year
Relative strength
+18%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $7 › 200d $8 — 200d above 50d
Institutional flow
Accumulating
+31 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.40% of float · ▲ +18.9% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
31 holders — 13F breadth
Squeeze score
81
high risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
83%
annualized · 1-yr
Max drawdown
−57%
past year
ATR
7.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+31%
Bullish
Price vs 50-day avg
+39%
Bullish
RSI (14)
76
Bearish
MACD trend
Positive
Bullish
52-week position
59%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $7 › 200d $8 — 200d above 50d
Institutional flow
Accumulating
+31 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.40% of float · ▲ +18.9% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
31 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $5
Now $10 · 59%
52-wk high $13
vs 200-day avg +31%
vs 50-day avg +39%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MSLE
this stock
Satellos Bioscience Inc.
|
$206.65M | +66.5% | — | — | 0.4% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +9.5% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.63B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MSLE | +31.9% | +66.5% | +27.5% | +25.9% | +66.5% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | +30.6% | +62.4% | +18.4% | +24.8% | +55.8% |